Citizen Petition Reform Under Consideration By FDA
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA Chief Counsel Bradshaw says options include creating a two-track process – under which ANDAs could be approved while petitions are still under review – or declaring some petitions frivolous.
You may also be interested in...
Pfizer Citizen Petition Calls For Recall Of Zithromax Generics
Company also files patent litigation against generic azithromycin manufacturers Teva and Sandoz.
Pfizer Citizen Petition Calls For Recall Of Zithromax Generics
Company also files patent litigation against generic azithromycin manufacturers Teva and Sandoz.
FDA Chief Counsel Bradshaw's "Practical" Approach Applauded By Barr
Barr CEO Bruce Downey is praising FDA Chief Counsel Sheldon Bradshaw's attitude towards issues affecting the generic drug industry